Linked Life Data

1993177

Source:http://linkedlifedata.com/resource/pubmed/id/1993177

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1993177rdf:typepubmed:Citationlld:pubmed
pubmed-article:1993177lifeskim:mentionsumls-concept:C0019704lld:lifeskim
pubmed-article:1993177lifeskim:mentionsumls-concept:C0220806lld:lifeskim
pubmed-article:1993177lifeskim:mentionsumls-concept:C0030946lld:lifeskim
pubmed-article:1993177lifeskim:mentionsumls-concept:C1999216lld:lifeskim
pubmed-article:1993177lifeskim:mentionsumls-concept:C0439855lld:lifeskim
pubmed-article:1993177lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:1993177lifeskim:mentionsumls-concept:C0678594lld:lifeskim
pubmed-article:1993177lifeskim:mentionsumls-concept:C2699488lld:lifeskim
pubmed-article:1993177pubmed:issue6lld:pubmed
pubmed-article:1993177pubmed:dateCreated1991-3-15lld:pubmed
pubmed-article:1993177pubmed:abstractTextThe crystal structure of a complex between chemically synthesized human immunodeficiency virus type 1 (HIV-1) protease and an octapeptide inhibitor has been refined to an R factor of 0.138 at 2.5-A resolution. The substrate-based inhibitor, H-Val-Ser-Gln-Asn-Leu psi [CH(OH)CH2]Val-Ile-Val-OH (U-85548e) contains a hydroxyethylene isostere replacement at the scissile bond that is believed to mimic the tetrahedral transition state of the proteolytic reaction. This potent inhibitor has Ki less than 1 nM and was developed as an active-site titrant of the HIV-1 protease. The inhibitor binds in an extended conformation and is involved in beta-sheet interactions with the active-site floor and flaps of the enzyme, which form the substrate/inhibitor cavity. The inhibitor diastereomer has the S configuration at the chiral carbon atom of the hydroxyethylene insert, and the hydroxyl group is within H-bonding distance of the two active-site carboxyl groups in the enzyme dimer. The two subunits of the enzyme are related by a pseudodyad, which superposes them at a 178 degrees rotation. The main difference between the subunits is in the beta turns of the flaps, which have different conformations in the two monomers. The inhibitor has a clear preferred orientation in the active site and the alternative conformation, if any, is a minor one (occupancy of less than 30%). A new model of the enzymatic mechanism is proposed in which the proteolytic reaction is viewed as a one-step process during which the nucleophile (water molecule) and electrophile (an acidic proton) attack the scissile bond in a concerted manner.lld:pubmed
pubmed-article:1993177pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1993177pubmed:languageenglld:pubmed
pubmed-article:1993177pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1993177pubmed:citationSubsetIMlld:pubmed
pubmed-article:1993177pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1993177pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1993177pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1993177pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1993177pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1993177pubmed:statusMEDLINElld:pubmed
pubmed-article:1993177pubmed:monthFeblld:pubmed
pubmed-article:1993177pubmed:issn0006-2960lld:pubmed
pubmed-article:1993177pubmed:authorpubmed-author:KentS BSBlld:pubmed
pubmed-article:1993177pubmed:authorpubmed-author:SchneiderJJlld:pubmed
pubmed-article:1993177pubmed:authorpubmed-author:HeinriksonR...lld:pubmed
pubmed-article:1993177pubmed:authorpubmed-author:SawyerT KTKlld:pubmed
pubmed-article:1993177pubmed:authorpubmed-author:TomasselliA...lld:pubmed
pubmed-article:1993177pubmed:authorpubmed-author:WlodawerAAlld:pubmed
pubmed-article:1993177pubmed:authorpubmed-author:StaplesD GDGlld:pubmed
pubmed-article:1993177pubmed:authorpubmed-author:JaskólskiMMlld:pubmed
pubmed-article:1993177pubmed:issnTypePrintlld:pubmed
pubmed-article:1993177pubmed:day12lld:pubmed
pubmed-article:1993177pubmed:volume30lld:pubmed
pubmed-article:1993177pubmed:ownerNLMlld:pubmed
pubmed-article:1993177pubmed:authorsCompleteYlld:pubmed
pubmed-article:1993177pubmed:pagination1600-9lld:pubmed
pubmed-article:1993177pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:1993177pubmed:meshHeadingpubmed-meshheading:1993177-...lld:pubmed
pubmed-article:1993177pubmed:meshHeadingpubmed-meshheading:1993177-...lld:pubmed
pubmed-article:1993177pubmed:meshHeadingpubmed-meshheading:1993177-...lld:pubmed
pubmed-article:1993177pubmed:meshHeadingpubmed-meshheading:1993177-...lld:pubmed
pubmed-article:1993177pubmed:meshHeadingpubmed-meshheading:1993177-...lld:pubmed
pubmed-article:1993177pubmed:meshHeadingpubmed-meshheading:1993177-...lld:pubmed
pubmed-article:1993177pubmed:meshHeadingpubmed-meshheading:1993177-...lld:pubmed
pubmed-article:1993177pubmed:meshHeadingpubmed-meshheading:1993177-...lld:pubmed
pubmed-article:1993177pubmed:meshHeadingpubmed-meshheading:1993177-...lld:pubmed
pubmed-article:1993177pubmed:meshHeadingpubmed-meshheading:1993177-...lld:pubmed
pubmed-article:1993177pubmed:meshHeadingpubmed-meshheading:1993177-...lld:pubmed
pubmed-article:1993177pubmed:meshHeadingpubmed-meshheading:1993177-...lld:pubmed
pubmed-article:1993177pubmed:year1991lld:pubmed
pubmed-article:1993177pubmed:articleTitleStructure at 2.5-A resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene-based inhibitor.lld:pubmed
pubmed-article:1993177pubmed:affiliationMacromolecular Structure Laboratory, National Cancer Institute-Frederick Cancer Research and Development Center, Maryland 21702-1201.lld:pubmed
pubmed-article:1993177pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1993177pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1993177lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1993177lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1993177lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1993177lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1993177lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1993177lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1993177lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1993177lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1993177lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1993177lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1993177lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1993177lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1993177lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1993177lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1993177lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1993177lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1993177lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1993177lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1993177lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1993177lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1993177lld:pubmed